The Alliance for Patient Access / What's New / ***MEDIA ADVISORY*** Thursday Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

***MEDIA ADVISORY*** Thursday Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

Summit will explore policies impacting patient access to biologic and biosimilar medications

 WASHINGTON – Tomorrow the Institute for Patient Access and Biologics Prescribers Collaborative, a project of the Alliance for Patient Access, will host the 2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars in Washington, DC. The summit will explore timely state and federal policy issues impacting patient access to approved biologic therapies and their biosimilar counterparts. The summit, held at the Ronald Reagan Building and International Trade Center, will feature remarks by Senator Bill Cassidy, M.D. (R-La.), FDA official Leah Christl, Ph.D, and Shannon Miller, decorated Olympic gymnast and cancer survivor. The summit is open to the press. Press interested in attending should RSVP to Susan Hepworth at [email protected].

WHO:           Health care providers, patient advocates and representatives from national physician associations

WHAT:           2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars

WHERE:        Ronald Reagan Building and International Trade Center – Rotunda Room

1300 Pennsylvania Avenue NW

Washington, DC

WHEN:           Thursday, April 6, 9:15 a.m. to 2:45 p.m.

agenda

Resources

Biologics Prescribers Collaborative                                               http://biologicsprescribers.org

Alliance for Patient Access                                                           http://allianceforpatientaccess.org

About AfPA Digital

The Alliance for Patient Access is a national network of physicians dedicated to ensuring patient access to approved therapies and appropriate clinical care.
Back to Top